Serum beta-2 microglobulin level in sympathetic ophthalmitis.

Area of Science:

• Ophthalmology
• Immunology
• Biomarker Research

Background:

• Sympathetic ophthalmitis is a rare but serious bilateral inflammation following ocular trauma.
• Accurate diagnosis and monitoring of sympathetic ophthalmitis are crucial for effective treatment.
• Beta-2 microglobulin (beta 2-m) is a protein found on cell surfaces, potentially indicating inflammatory processes.

Purpose of the Study:

• To investigate serum beta-2 microglobulin (beta 2-m) levels in patients with sympathetic ophthalmitis and traumatic uveitis.
• To assess the potential of beta 2-m as a diagnostic and prognostic marker for sympathetic ophthalmitis.
• To correlate beta 2-m levels with disease activity and treatment response.

Main Methods:

• Serum samples were collected from 12 patients with sympathetic ophthalmitis, 34 with neglected traumatic uveitis, and 36 healthy controls.
• Enzyme-linked immunosorbent assay (ELISA) was employed to quantify serum beta-2 microglobulin (beta 2-m) levels.
• Statistical analysis was performed to compare beta 2-m levels across different patient groups and disease stages.

Main Results:

• Serum beta-2 microglobulin (beta 2-m) levels were significantly elevated in patients with sympathetic ophthalmitis compared to healthy controls and traumatic uveitis patients.
• No significant alteration in beta 2-m levels was observed in patients with traumatic uveitis alone.
• Elevated beta 2-m levels correlated with disease severity, decreased during remission, and rose again during relapse.

Conclusions:

• Serum beta-2 microglobulin (beta 2-m) shows promise as a diagnostic aid for sympathetic ophthalmitis, especially in ambiguous clinical cases.
• A rise in serum beta 2-m in traumatic uveitis patients may indicate the onset of sympathetic ophthalmitis.
• Beta-2 microglobulin serves as a valuable tool for assessing disease severity, evaluating drug efficacy, and predicting relapse in sympathetic ophthalmitis.